You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint InhibitorsDrug Independence by Combinations with Checkpoint Inhibitors
|
---|---|
Published in |
Clinical Cancer Research, January 2022
|
DOI | 10.1158/1078-0432.ccr-21-2275 |
Pubmed ID | |
Authors |
Adam C. Palmer, Benjamin Izar, Haeun Hwangbo, Peter K. Sorger |
X Demographics
The data shown below were collected from the profiles of 131 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 44 | 34% |
United Kingdom | 6 | 5% |
Canada | 4 | 3% |
Australia | 3 | 2% |
Switzerland | 2 | 2% |
Sweden | 2 | 2% |
France | 2 | 2% |
Spain | 2 | 2% |
Norway | 2 | 2% |
Other | 13 | 10% |
Unknown | 51 | 39% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 68 | 52% |
Scientists | 49 | 37% |
Practitioners (doctors, other healthcare professionals) | 11 | 8% |
Science communicators (journalists, bloggers, editors) | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 103 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 31 | 30% |
Other | 16 | 16% |
Student > Ph. D. Student | 7 | 7% |
Student > Bachelor | 7 | 7% |
Student > Doctoral Student | 4 | 4% |
Other | 8 | 8% |
Unknown | 30 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 16% |
Biochemistry, Genetics and Molecular Biology | 14 | 14% |
Immunology and Microbiology | 12 | 12% |
Agricultural and Biological Sciences | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Other | 14 | 14% |
Unknown | 35 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 148. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2024.
All research outputs
#285,352
of 25,805,386 outputs
Outputs from Clinical Cancer Research
#122
of 13,322 outputs
Outputs of similar age
#8,323
of 520,814 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 214 outputs
Altmetric has tracked 25,805,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,322 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.